Literature DB >> 28473215

Management of Nonagenarian Patients With Severe Aortic Stenosis: The Role of Comorbidity.

Eva Bernal1, Albert Ariza-Solé2, Antoni Bayés-Genís1, Francesc Formiga3, Pablo Díez-Villanueva4, Rafael Romaguera3, Hugo González-Saldívar5, Manuel Martínez-Sellés6.   

Abstract

BACKGROUND: The number of nonagenarian patients with aortic stenosis will likely increase due to the ageing population. We assessed the clinical characteristics, management, and outcomes of nonagenarian patients with severe aortic stenosis.
METHODS: A total of 177 (117 females and 60 males) consecutive nonagenarian patients from two large contemporary registries were included in this study. Clinical characteristics, comorbidity as assessed by the Charlson Index, clinical management, and outcomes were recorded. The main outcome measure was 1-year mortality.
RESULTS: The mean patient age was 91.1 years, and 56 patients (31.6%) had a Charlson Index <3. A strong association between comorbidity and 1-year overall mortality was observed, with higher 1-year mortality in patients with Charlson Index ≥3 (66.4% vs. 32.1%, p<0.001). A total of 150 patients (84.7%) were managed conservatively, and 27 (15.3%) underwent transcatheter aortic valve implantation (TAVI). Predictors of a conservative management were treatment out of TAVI centres, lower mean aortic gradient and better functional class. Clinical management was not significantly different with different degrees of comorbidity. A trend toward higher mortality in patients undergoing conservative management was observed (58% vs. 40.7%, p=0.097). Independent predictors of mortality were higher Charlson Index, lower creatinine clearance, lower mean aortic gradient, poorer left ventricular ejection fraction, significant mitral regurgitation and conservative management.
CONCLUSIONS: About one third of nonagenarians with severe aortic stenosis have few comorbidities. The clinical management was similar irrespective of the Charlson Index. Both higher Charlson Index values and a conservative management were independently associated with a higher mortality.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Comorbidity; Management; Nonagenarian; Prognosis; TAVI

Mesh:

Year:  2017        PMID: 28473215     DOI: 10.1016/j.hlc.2017.02.033

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  3 in total

1.  Transcatheter aortic valve implantation in nonagenarians: selectively feasible or extravagantly futile?

Authors:  Antonis S Manolis; Antonis A Manolis
Journal:  Ann Cardiothorac Surg       Date:  2017-09

2.  Clinical Outcomes of Transcatheter Aortic Valve Replacement in Nonagenarians: A Systematic Review and Meta-Analysis.

Authors:  Yan Liu; Yu Du; Mingjie Fu; Yue Ma; Deguang Wang; Jinglin Zhang; Wei Liu; Yingxin Zhao; Yujie Zhou
Journal:  J Interv Cardiol       Date:  2019-02-24       Impact factor: 2.279

Review 3.  Transcatheter aortic valve replacement over age 90: Risks vs benefits.

Authors:  Christos Galatas; Jonathan Afilalo
Journal:  Clin Cardiol       Date:  2019-12-16       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.